Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & Administrative
Others
Ratios

Pasithea Therapeutics (KTTA) Other Operating Expenses (2022)

Pasithea Therapeutics (KTTA) has disclosed Other Operating Expenses for 1 consecutive years, with -$3.1 million as the latest value for Q2 2022.

  • Quarterly Other Operating Expenses changed N/A to -$3.1 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was -$3.1 million through Mar 2023, changed N/A year-over-year, with the annual reading at -$1.0 million for FY2022, N/A changed from the prior year.
  • Other Operating Expenses hit -$3.1 million in Q2 2022 for Pasithea Therapeutics.
  • In the past five years, Other Operating Expenses ranged from a high of -$3.1 million in Q2 2022 to a low of -$3.1 million in Q2 2022.